Unlike traditional biomarkers such as anti-dsDNA antibodies—which primarily reflect systemic autoimmune status—IL-18 correlates more specifically and sensitively with renal inflammatory activity and pathological severity (e.g., in Class IV LN). The gene discussed is IL18; the disease is lobular neoplasia.